| CHMP1B |
CHMP1B, C18orf2: Charged multivesicular body protein 1b |
CHMP4C |
CHMP4C, SHAX3: Charged multivesicular body protein 4c |
31.610 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
HFE |
HFE, HLAH: Hereditary hemochromatosis protein precursor |
31.610 |
Evidence |
|
| BAX |
BAX: Apoptosis regulator BAX, cytoplasmic isoform beta |
BIK |
BIK, NBK: Bcl-2-interacting killer |
31.610 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
31.610 |
Evidence |
|
| CHMP1B |
CHMP1B, C18orf2: Charged multivesicular body protein 1b |
CHMP4B |
CHMP4B, C20orf178, SHAX1: Charged multivesicular body protein 4b |
31.610 |
Evidence |
|
| GABRB3 |
GABRB3: Gamma-aminobutyric acid receptor subunit beta-3 precursor |
CHRNA2 |
CHRNA2: Neuronal acetylcholine receptor subunit alpha-2 precursor |
31.610 |
Evidence |
|
| BAX |
BAX: Apoptosis regulator BAX, cytoplasmic isoform beta |
BAK1 |
IPI00003352 |
31.610 |
Evidence |
|
| ITGA4 |
ITGA4, CD49D: Integrin alpha-4 precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
31.590 |
Evidence |
|
| ACTC |
ACTC1, ACTC: Actin, alpha cardiac muscle 1 |
ACTA1 |
ACTA1, ACTA: Actin, alpha skeletal muscle |
31.570 |
Evidence |
|
| B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
LILRB1 |
IPI00385703 |
31.520 |
Evidence |
|
| RFC4 |
RFC4: Replication factor C subunit 4 |
TAF9 |
AK6, AD-004, CGI-137: Adenylate kinase isoenzyme 6 |
31.480 |
Evidence |
|
| CCNF |
CCNF: G2/mitotic-specific cyclin-F |
MCM6 |
MCM6: DNA replication licensing factor MCM6 |
31.480 |
Evidence |
|
| JUNB |
JUNB: Transcription factor jun-B |
ELF4 |
ELF4, ELFR, MEF: ETS-related transcription factor Elf-4 |
31.480 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
CCNF |
CCNF: G2/mitotic-specific cyclin-F |
31.480 |
Evidence |
|
| MCM7 |
MCM7, CDC47, MCM2: DNA replication licensing factor MCM7 |
CCNF |
CCNF: G2/mitotic-specific cyclin-F |
31.480 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
NAP1L1 |
NAP1L1, NRP: Nucleosome assembly protein 1-like 1 |
31.470 |
Evidence |
|
| EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
EIF2S3 |
EIF2S3, EIF2G: Eukaryotic translation initiation factor 2 subunit 3 |
31.470 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
PRL |
PRL: Prolactin precursor |
31.440 |
Evidence |
|
| F10 |
F10: Coagulation factor X precursor |
PRL |
PRL: Prolactin precursor |
31.440 |
Evidence |
|
| EIF4G3 |
EIF4G3: Eukaryotic translation initiation factor 4 gamma 3 |
DRG1 |
DRG1, NEDD3: Developmentally-regulated GTP-binding protein 1 |
31.440 |
Evidence |
|
| PSMC1 |
PSMC1: 26S protease regulatory subunit 4 |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
31.420 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CD36 |
CD36, GP3B, GP4: Platelet glycoprotein 4 |
31.420 |
Evidence |
|
| MYH9 |
MYH9: Myosin-9 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
31.420 |
Evidence |
|
| CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
31.410 |
Evidence |
|
| SNRPD3 |
SNRPD3: Small nuclear ribonucleoprotein Sm D3 |
DDX47 |
E4-DBP: DEAD box protein |
31.410 |
Evidence |
|
-